81 related articles for article (PubMed ID: 11955369)
21. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
[TBL] [Abstract][Full Text] [Related]
22. Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor.
Popik W; Pitha PM
Virology; 1998 Dec; 252(1):210-7. PubMed ID: 9875330
[TBL] [Abstract][Full Text] [Related]
23. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
Reffas S; Schlegel W
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
25. The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells.
Elder DJ; Halton DE; Playle LC; Paraskeva C
Int J Cancer; 2002 May; 99(3):323-7. PubMed ID: 11992399
[TBL] [Abstract][Full Text] [Related]
26. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
27. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells.
Veit C; Genze F; Menke A; Hoeffert S; Gress TM; Gierschik P; Giehl K
Cancer Res; 2004 Aug; 64(15):5291-300. PubMed ID: 15289335
[TBL] [Abstract][Full Text] [Related]
28. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
29. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.
Vintman L; Nielsen S; Berner A; Reich R; Davidson B
Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375
[TBL] [Abstract][Full Text] [Related]
30. Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.
Hoffmann K; Shibo L; Xiao Z; Longerich T; Büchler MW; Schemmer P
Anticancer Res; 2011 Nov; 31(11):3883-90. PubMed ID: 22110214
[TBL] [Abstract][Full Text] [Related]
31. Immunolocalization of the mitogen-activated protein kinase signaling pathway in Hassall's corpuscles of the human thymus.
Nishio H; Matsui K; Tsuji H; Tamura A; Suzuki K
Acta Histochem; 2001 Feb; 103(1):89-98. PubMed ID: 11252631
[TBL] [Abstract][Full Text] [Related]
32. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex.
Whisler RL; Newhouse YG; Bagenstose SE
Cell Immunol; 1996 Mar; 168(2):201-10. PubMed ID: 8640866
[TBL] [Abstract][Full Text] [Related]
33. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
34. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF.
McLeish KR; Knall C; Ward RA; Gerwins P; Coxon PY; Klein JB; Johnson GL
J Leukoc Biol; 1998 Oct; 64(4):537-45. PubMed ID: 9766635
[TBL] [Abstract][Full Text] [Related]
35. Temporal and spatial profile of phosphorylated mitogen-activated protein kinase pathways after lateral fluid percussion injury in the cortex of the rat brain.
Otani N; Nawashiro H; Fukui S; Nomura N; Shima K
J Neurotrauma; 2002 Dec; 19(12):1587-96. PubMed ID: 12542859
[TBL] [Abstract][Full Text] [Related]
36. Expression of Mitogen-Activated Protein Kinases in Chronic Subdural Hematoma Outer Membranes.
Aoyama M; Osuka K; Usuda N; Watanabe Y; Kawaguchi R; Nakura T; Takayasu M
J Neurotrauma; 2015 Jul; 32(14):1064-70. PubMed ID: 25496293
[TBL] [Abstract][Full Text] [Related]
37. Repeated fasting stress causes activation of mitogen-activated protein kinases (ERK/JNK) in rat liver.
Nishio H; Kuwabara H; Mori H; Suzuki K
Hepatology; 2002 Jul; 36(1):72-80. PubMed ID: 12085351
[TBL] [Abstract][Full Text] [Related]
38. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
39. Lipoteichoic acid selectively induces the ERK signaling pathway in the cornea.
You L; Kruse FE; Bacher S; Schmitz ML
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2272-7. PubMed ID: 12091427
[TBL] [Abstract][Full Text] [Related]
40. Expression of down stream molecules of RET (p-ERK, p-p38 MAPK, p-JNK and p-AKT) in papillary thyroid carcinomas.
Shin E; Hong SW; Kim SH; Yang WI
Yonsei Med J; 2004 Apr; 45(2):306-13. PubMed ID: 15119004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
